Aids Research And Human Retroviruses

Journal Title：Aids Research And Human Retroviruses

AIDS Research and Human Retroviruses was the very first AIDS publication in the field over 30 years ago, and today it is still the critical resource advancing research in retroviruses, including AIDS. The Journal provides the broadest coverage from molecular biology to clinical studies and outcomes research, focusing on developments in prevention science, novel therapeutics, and immune-restorative approaches. Cutting-edge papers on the latest progress and research advances through clinical trials and examination of targeted antiretroviral agents lead to improvements in translational medicine for optimal treatment outcomes.

AIDS Research and Human Retroviruses coverage includes:

HIV cure research

HIV prevention science

- Vaccine research

- Systemic and Topical PreP

Molecular and cell biology of HIV and SIV

Developments in HIV pathogenesis and comorbidities

Molecular biology, immunology, and epidemiology of HTLV

Pharmacology of HIV therapy

Social and behavioral science

Rapid publication of emerging sequence information.

AIDS Research and Human Retroviruses 是 30 多年前该领域的第一个 AIDS 出版物，今天它仍然是推动包括 AIDS 在内的逆转录病毒研究的关键资源。该杂志提供从分子生物学到临床研究和结果研究的最广泛报道，重点关注预防科学、新疗法和免疫恢复方法的发展。通过临床试验和靶向抗逆转录病毒药物的检查，有关最新进展和研究进展的前沿论文促进了转化医学的改进，以实现最佳治疗结果。

艾滋病研究和人类逆转录病毒的报道包括：

HIV治愈研究

艾滋病预防科学

- 疫苗研究

- 全身和局部准备

HIV和SIV的分子和细胞生物学

HIV 发病机制和合并症的发展

HTLV 的分子生物学、免疫学和流行病学

HIV 治疗的药理学

社会和行为科学

新兴序列信息的快速发布。

Aids Research And Human Retroviruses创刊于1987年，由MARY ANN LIEBERT, INC出版商出版，收稿方向涵盖医学 - 病毒学全领域，此期刊水平偏中等偏靠后，在所属细分领域中专业影响力一般，过审相对较易，如果您文章质量佳，选择此期刊，发表机率较高。平均审稿速度一般,3-6周，影响因子指数1.765，该期刊近期没有被列入国际期刊预警名单，广大学者值得一试。